Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate: A Vital Link in Cancer Therapy Production

Discover the significance of Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate, a high-purity pharmaceutical intermediate crucial for the synthesis of Lenvatinib, a leading targeted therapy for various cancers. Explore its chemical properties and manufacturing importance.

Get a Quote & Sample

Advantages of Our Product

Uncompromised Purity

Our commitment to quality guarantees a minimum purity of 98.0% (HPLC) for Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate, ensuring optimal performance in the synthesis of lenvatinib.

Critical for Oncology

This compound serves as a vital pharmaceutical intermediate in the production of Lenvatinib, a key drug in treating various forms of cancer, directly impacting patient outcomes.

Reliable Sourcing

We are a dedicated lenvatinib intermediate supplier in China, offering dependable sourcing and consistent production to meet the demands of global pharmaceutical companies.

Key Applications

Lenvatinib Synthesis

This chemical is indispensable as a primary pharmaceutical intermediate for the synthesis of Lenvatinib Mesylate, a groundbreaking oncology medication.

Cancer Drug Development

Its role as a building block in targeted cancer therapies makes it crucial for cancer drug development and research, enabling new treatment avenues.

Impurity Reference Standard

As a known impurity or reference standard for Lenvatinib, it is critical for rigorous quality control and analytical testing in pharmaceutical production.

Fine Chemical Manufacturing

Beyond pharmaceuticals, its quinoline structure and functional groups make it valuable in other areas of fine chemical manufacturing and research.